Radiotherapy for ovarian cancers - redefining the role

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 12, 2014, Pages 4759-4763

  Rai, Bhavana ^a   Bansal, Anshuma ^a   Patel, Firuza Darius ^a   Sharma, Suresh Chander ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Chemotherapy; Ovarian cancer; Radiation therapy

Indexed keywords

ANIMAL; FEMALE; HUMAN; OVARIAN NEOPLASMS;

ANIMALS; FEMALE; HUMANS; OVARIAN NEOPLASMS; RADIOTHERAPY;

EID: 84904608777     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.12.4759     Document Type: Short Survey

References (29)

1. Bhurgri Y, Shaheen Y, Kayani N, et al (2011). Incidence, trends and morphology of ovarian cancer in Karachi (1995-2002). Asian Pac J Cancer Prev, 12, 1567-71.
2. Biete A, Valduvieco I, Rovirosa A, et al (2010). Whole abdominal radiotherapy in ovarian cancer. Rep Pract Oncol Radiother, 15, 27-30.
3. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002). Survival effect of maximal cytoreducti ve surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol, 20, 1248-59.
4. Brown AP, Jhingran A, Klopp AH, et al (2013). Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol, 130, 300-5.
5. Chang JS, Koom WS, Kim SW, et al (2013). Risk stratification of abdominopelvic failure for FIGO stage III epithelial ovarian cancer patients: implications for adjuvant radiotherapy. J Gynecol Oncol, 24, 146-53.
6. Corn BW, Lanciano RM, Boente M, et al (1994). Recurrent ovarian cancer. Effective radiotherapeutic palliation after chemotherapy failure. Cancer, 74, 2979-83.
7. De Meerleer G, Vandecasteele K, Ost P, et al (2011). Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience. Int J Radiat Oncol Biol Phys, 79,775-81.
8. Dembo AJ (1992). Epithelial ovarian cancer: the role of radiotherapy. Int J Radiat Oncol Biol Phys, 22, 835-45.
9. Dembo A J, Bush RS (1982). Choice of postoperative therapy based on prognostic factors. Int J Radiat Oncol Biol Phys, 8, 893-7.
10. Dembo AJ, Bush RS, Beale FA, et al (1979). Improved survival following abdominopelvic irradiation in patients with a completed pelvic operation. Am J Obstet Gynecol, 134, 793-800.
11. Eltabbakh GH, Goodrich S (2006). Update on the treatment of recurrent ovarian cancer. Womens Health (Lond Engl), 2, 127-39.
12. Gocheva L (2003). Whole abdomen irradiation in epithelial ovarian cancer-state of the art. Wspotczesna Onkologia, 13, 181-90.
13. Hoskins PJ, Le N, Gilks B, et al (2012). Low-stage ovarian clear cell carcinoma: population-based outcomes in British Columbia, Canada, with evidence for a survival benefit as a result of irradiation. J Clin Oncol, 30, 1656-62.
14. Kobel M, Kalloger SE, Huntsman DG, et al (2010). Differences in tumor type in low-stage versus high-stage ovarian carcinomas. Int J Gynecol Pathol, 29, 203-11.
15. Kojs Z, Glinski B, Reinfuss M, et al (2001). Results of a randomized prospective trial comparing postoperative abdominopelvic radiotherapy with postoperative chemotherapy in early ovarian cancer. Cancer Radiother, 5,5-11.
16. Mahantshetty U, Jamema S, Engineer R, et al (2010). Whole abdomen radiation therapy in ovarian cancers: a comparison between fixed beam and volumetric arc based intensity modulation. Radiat Oncol, 15, 106.
17. Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A (2009). Changing trends in incidence of ovarian cancer-the Indian scenario. Asian Pac J Cancer Prev, 10, 1025-30.
18. Nagai Y, Inamine M, Hirakawa M, et al (2007). Postoperative whole abdominal radiotherapy in clear cell adenocarcinoma of the ovary. Gynecol Oncol, 107, 469-73.
19. Ozols RF (1997): Controversies in the management of ovarian cancer. Int J Gynecol Cancer, 7, 27-32.
20. Quon M, Gallant V, Samant R (2006). Effective palliative radiotherapy for symptomatic recurrent or residual ovarian cancer. Gynecol 102, 204-9.
21. Rochet N, Kieser M, Sterzing F, et al (2011). Phase II study evaluating consolidation whole abdominal intensity-modulated radiotherapy (IMRT) in patients with advanced ovarian cancer stage FIGO III--the OVAR-IMRT-02 Study. BMC Cancer, 28, 11-41.
22. Rochet N, Sterzing F, Jensen AD, et al (2010). Intensity-modulated whole abdominal radiotherapy after surgery and carboplatin/taxane chemotherapy for advanced ovarian cancer: phase I study. Int J Radiat Oncol Biol Phys, 76, 1382-9.
23. Shetty UM, Shankar S, Engineer R, et al (2013). Image guided intensity modulated whole abdomen radiation therapy in relapsed epithelial ovarian cancers: a feasibility study.J Can Res Ther, 9, 17-21.
24. Sirichaisutdhikorn D, Suprasert P, Khunamornpong S (2009). Clinical outcome of the ovarian clear cell carcinoma compared to other epithelial ovarian cancers when treated with paclitaxel and carboplatin. Asian Pac J Cancer Prev, 10, 1041-5.
25. Sorbe B (2003). Consolidation treatment of advanced (FIGO stage III) ovarian carcinoma in complete surgical remission after induction chemotherapy: a randomized, controlled, clinical trial comparing whole abdominal radiotherapy, chemotherapy, and no further treatment. Int J Gynecol Cancer, 13, 276-8.
26. Suprasert P, Manopunya M, Cheewakriangkrai C (2014). Outcomes with single agent LIPO-DOX in platinum-resistant ovarian and fallopian tube cancers and primary peritoneal adenocarcinoma- Chiang Mai University Hospital Experience. Asian Pac J Cancer Prev, 15, 1145-8.
27. Swenerton KD, Santos JL, Gilks CB, et al (2011). Histotype predicts the curative potential of radiotherapy: The example of ovarian cancers. Ann Oncol, 22, 341-7.
28. Thomas G (2013). Revisiting the role of radiation treatment for non-serous subtypes of epithelial ovarian cancer. Am Soc Clin Oncol Educ Book, 31, e205.
29. Yahara K, Ohguri T, Imada H, et al (2013). Epithelial ovarian cancer: definitive radiotherapy for limited recurrence after complete remission had been achieved with aggressive front-line therapy. J Radiat Res, 54, 322-9.